Literature DB >> 33712571

Overexpression of Annexin A2 promotes proliferation by forming a Glypican 1/c-Myc positive feedback loop: prognostic significance in human glioma.

Xin Li1,2, Shengdan Nie3, Ziyang Lv2, Lingran Ma2, Yuxi Song2, Zhongxu Hu1, Xin Hu2, Zhiqiang Liu1, Gaoya Zhou4, Zhijie Dai5, Tao Song6, Jiajia Liu7, Shan Wang8.   

Abstract

In order to set up a reliable prediction system for the tumor grade and prognosis in glioma patients, we clarify the complicated crosstalk of Annexin A2 (ANXA2) with Glypican 1 (GPC1) and demonstrate whether combined indexes of ANXA2 and GPC1 could improve the prognostic evaluation for glioma patients. We found that ANXA2-induced glioma cell proliferation in a c-Myc-dependent manner. ANXA2 increased the expression of GPC1 via c-Myc and the upregulated GPC1 further promoted the c-Myc level, forming a positive feedback loop, which eventually led to enhanced proliferation of glioma cells. Both mRNA and protein levels of ANXA2 were upregulated in glioma tissues and coincided with the overexpression of GPC1. Besides, we utilized tissue microarrays (TMAs) and immunohistochemistry to demonstrate that glioma patients with both high expression of ANXA2 and GPC1 tended to have higher rate of tumor recurrence and shorter overall survival (OS). In conclusion, the overexpression of ANXA2 promotes proliferation of glioma cells by forming a GPC1/c-Myc positive feedback loop, and ANXA2 together with its downstream target GPC1 could be a potential "combination biomarker" for predicting prognosis of glioma patients.

Entities:  

Year:  2021        PMID: 33712571      PMCID: PMC7954792          DOI: 10.1038/s41419-021-03547-5

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  49 in total

Review 1.  Malignant Intracranial High Grade Glioma and Current Treatment Strategy.

Authors:  Xiang Zhang; Wei Zhang; Xing-Gang Mao; Wei-Dong Cao; Hai-Ning Zhen; Shi-Jie Hu
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

2.  Annexin A2 regulates glioma cell proliferation through the STAT3‑cyclin D1 pathway.

Authors:  Ling Chen; Ling Lin; Na Xian; Zhihong Zheng
Journal:  Oncol Rep       Date:  2019-05-09       Impact factor: 3.906

3.  Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma.

Authors:  Li Li; Ronghua Jin; Xiaoli Zhang; Fudong Lv; Lifeng Liu; Daojie Liu; Kai Liu; Ning Li; Dexi Chen
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

4.  High Expression of Glypican-1 Predicts Dissemination and Poor Prognosis in Glioblastomas.

Authors:  Taiichi Saito; Kazuhiko Sugiyama; Seiji Hama; Fumiyuki Yamasaki; Takeshi Takayasu; Ryo Nosaka; Shumpei Onishi; Yoshihiro Muragaki; Takakazu Kawamata; Kaoru Kurisu
Journal:  World Neurosurg       Date:  2017-09       Impact factor: 2.104

5.  Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms.

Authors:  Chi-Yun Wang; Chia-Ling Chen; Yau-Lin Tseng; Yi-Ting Fang; Yee-Shin Lin; Wu-Chou Su; Chien-Chin Chen; Kung-Chao Chang; Yi-Ching Wang; Chiou-Feng Lin
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

6.  Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.

Authors:  Haizhen Lu; Fangfei Niu; Fang Liu; Jiajia Gao; Yulin Sun; Xiaohang Zhao
Journal:  Cancer Med       Date:  2017-04-24       Impact factor: 4.452

7.  Annexin A2 Silencing Inhibits Proliferation and Epithelial-to-mesenchymal Transition through p53-Dependent Pathway in NSCLCs.

Authors:  Minhua Wu; Yanqin Sun; Feipeng Xu; Yanqing Liang; Hao Liu; Yanmei Yi
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

Review 8.  Glypicans.

Authors:  Jorge Filmus; Mariana Capurro; Jonathan Rast
Journal:  Genome Biol       Date:  2008-05-22       Impact factor: 13.583

9.  SEOM clinical guidelines for anaplastic gliomas (2017).

Authors:  A Hernandez; C Balañá; M Alonso; P Perez-Segura; E Pineda; A Ramos; A R Sanchez; P Teixidor; E Verger; M Benavides
Journal:  Clin Transl Oncol       Date:  2017-10-20       Impact factor: 3.405

10.  Annexin 2A sustains glioblastoma cell dissemination and proliferation.

Authors:  Francesca Maule; Silvia Bresolin; Elena Rampazzo; Daniele Boso; Alessandro Della Puppa; Giovanni Esposito; Elena Porcù; Stefania Mitola; Giuseppe Lombardi; Benedetta Accordi; Manuela Tumino; Giuseppe Basso; Luca Persano
Journal:  Oncotarget       Date:  2016-08-23
View more
  4 in total

1.  GPC1 promotes the growth and migration of colorectal cancer cells through regulating the TGF-β1/SMAD2 signaling pathway.

Authors:  Fei Lu; Shuran Chen; Weijun Shi; Xu Su; Huazhang Wu; Mulin Liu
Journal:  PLoS One       Date:  2022-06-07       Impact factor: 3.752

2.  ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.

Authors:  Kaiming Ma; Xin Chen; Weihai Liu; Yang Yang; Suhua Chen; Jianjun Sun; Changcheng Ma; Tao Wang; Jun Yang
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

3.  ANXA2P2: A Potential Immunological and Prognostic Signature in Ovarian Serous Cystadenocarcinoma via Pan-Carcinoma Synthesis.

Authors:  Yanna Zhang; Ting Du; Xiancheng Chen
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

4.  Brain Regeneration Resembles Brain Cancer at Its Early Wound Healing Stage and Diverges From Cancer Later at Its Proliferation and Differentiation Stages.

Authors:  Yeliz Demirci; Guillaume Heger; Esra Katkat; Irene Papatheodorou; Alvis Brazma; Gunes Ozhan
Journal:  Front Cell Dev Biol       Date:  2022-02-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.